The Relationship Between Asthma and Alpha-1 Antitrypsin Deficiency
Source: Pixabay.com

The Relationship Between Asthma and Alpha-1 Antitrypsin Deficiency

  Alpha-1 antitrypsin deficiency (A1AD) shares similarities with asthma, which leads to it often being misdiagnosed as asthma. This misdiagnosis leads to insufficient treatment. Toronto Western Hospital's Asthma and Airways…

Continue Reading The Relationship Between Asthma and Alpha-1 Antitrypsin Deficiency
Ganaxolone Being Investigated as Treatment for Tuberous Sclerosis and CDKL5 Deficiency Disorder
source: pixabay.com

Ganaxolone Being Investigated as Treatment for Tuberous Sclerosis and CDKL5 Deficiency Disorder

Marinus Pharmaceuticals is a pharmaceutical company that works to create treatments for epilepsy and other neuropsychiatric disorders. They are in the process of conducting clinical trials to evaluate the safety…

Continue Reading Ganaxolone Being Investigated as Treatment for Tuberous Sclerosis and CDKL5 Deficiency Disorder
Facebook Takes Action on Groups Promoting Black Salve, an Ineffective and Dangerous Cancer Treatment
source: pixabay.com

Facebook Takes Action on Groups Promoting Black Salve, an Ineffective and Dangerous Cancer Treatment

According to a story from Buzzfeed News, social media giant Facebook has finally taken action against groups on the site that promote the use of black salve, an alternative treatment…

Continue Reading Facebook Takes Action on Groups Promoting Black Salve, an Ineffective and Dangerous Cancer Treatment
XPOVIO Being Evaluated for Treatment of Diffuse Large B-Cell Lymphoma
Source: https://pixabay.com/en/white-blood-cell-cell-blood-cell-543471/

XPOVIO Being Evaluated for Treatment of Diffuse Large B-Cell Lymphoma

Karyopharm, a pharmaceutical company based in Newton, Massachusetts, has submitted a New Drug Application to the FDA for their drug XPOVIO, which is meant for the treatment of diffuse large…

Continue Reading XPOVIO Being Evaluated for Treatment of Diffuse Large B-Cell Lymphoma
Study: Odiparcil Shows Positive Results in Treatment of Mucopolysaccharidosis Type VI (MPS VI)
jarmoluk / Pixabay

Study: Odiparcil Shows Positive Results in Treatment of Mucopolysaccharidosis Type VI (MPS VI)

Inventiva has recently completed Phase IIa of their clinical trial of odiparcil, a drug made for the treatment of mucopolysaccharidosis type VI (MPS VI). Iventiva is very excited about the…

Continue Reading Study: Odiparcil Shows Positive Results in Treatment of Mucopolysaccharidosis Type VI (MPS VI)
Study: Belantamab Mafodotin Shows Positive Results in People with Multiple Myeloma
https://pixabay.com/en/blood-blood-plasma-red-blood-cells-75301/

Study: Belantamab Mafodotin Shows Positive Results in People with Multiple Myeloma

Copyscape score: 4% Cancer is a disease that affects different people in different ways, and for some people, no existing treatments can effectively treat their cancer. GlaxoSmithKline has recently released…

Continue Reading Study: Belantamab Mafodotin Shows Positive Results in People with Multiple Myeloma

VYNDAQEL® for treatment of Transthyretin Amyloid Cardiomyopathy Received Positive Opinion by the (EMA) 

  Pfizer issued a statement this week through its Media Relations that its drug VYNDAQEL® for treatment of Transthyretin Amyloid Cardiomyopathy received positive opinion by the  European Medicines Agency’s (EMA) Committee for…

Continue Reading VYNDAQEL® for treatment of Transthyretin Amyloid Cardiomyopathy Received Positive Opinion by the (EMA)